Kevin Cameron

Glass, Lewis & Co. LLC (Glass Lewis) is an independent investment research firm headquartered in San Francisco, California. The firm was founded in 2003 by Kevin J. Cameron & Gregory P. Taxin. Glass Lewis provides investment research and advice on proxy votes to institutional investor and?publicly listed?companies. Their clients include pension plans, mutual funds, and asset managers.

ProCure Treatment Centers, Inc. develops cancer treatment centers. The firm is dedicated to improving the lives of patients with cancer by increasing access to proton therapy, an alternative to traditional radiation. It provides design, construction, financing, staffing, training, and day-to-day operations of world-class proton therapy centers. The company was founded by John Montgomery Cameron in 2005 and is headquartered in Somerset, NJ.

Xyphos Biosciences, Inc. engages in biotechnology business. The firm’s novel and proprietary ACCEL (Advanced Cellular Control through Engineered Ligands) technology platform allows new ways to mobilize and control immune cells to find and destroy specifically targeted cells throughout the body. The company was founded by David W. Martin, Jr. and James L. Knighton and is headquartered in South San Francisco, CA.

Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA.

Ionetix Corp. engages in the development, manufacturing, and distribution of a novel class of superconductng cyclotrons for the point-of-care production of PET radioisotopes. It offers ION-12SC, a positron emission tomography (PET) radiopharmaceutical production system for producing N-13 ammonia (13NH3), which is used in PET myocardial perfusion imaging. The company is headquartered in Marblehead, MA.

AvidBiotics Corp. operates as a biotechnology company. It develops therapeutic proteins designed to destroy target cells with laser precision, including cancer cells, virus-infected cells, and pathogenic bacteria. The company was founded by David W. Martin, James L. Knighton, and Jeffrey F. Miller in 2005 and is headquartered in South San Francisco, CA.